NewsDirect-acting antiviral to treat COVID-19 developed in
QLD

17th May 2021by admin0
https://nfusion-tech.com/wp-content/uploads/2021/05/direct-acting-antiviral-to-treat-covid-19-developed-inqld_60a390a84a7a8.jpeg

An international team of scientists from the Menzies
Health Institute Queensland (MHIQ) at Griffith University and from
City of Hope, a research and treatment center for cancer, diabetes
and other life-threatening diseases in the US, has developed an
experimental direct-acting antiviral therapy to treat
COVID-19.

Leave a Reply

Your email address will not be published. Required fields are marked *

https://nfusion-tech.com/wp-content/uploads/2019/10/Logo_newfusion-footer.png
https://nfusion-tech.com/wp-content/uploads/2019/10/Logo_newfusion-footer.png
Subscribe

If you wish to receive our latest news in your email box, just subscribe to our newsletter. We won’t spam you, we promise!

    New Fusion

    The New Fusion technology is based on a phenomenon called triplet-triplet annihilation (TTA) which is a process in which two triplet excitons annihilate and produce a higher energy singlet exciton.

    Subscribe

    If you wish to receive our latest news in your email box, just subscribe to our newsletter. We won’t spam you, we promise!

      New Fusion

      The New Fusion technology is based on a phenomenon called triplet-triplet annihilation (TTA) which is a process in which two triplet excitons annihilate and produce a higher energy singlet exciton.

      Copyright @2021 New Fusion All Rights Reserved

      Designed by FallingBrick